AAAAAA
Results: 1-25/85
Authors:
Johnson, FN
Johnson, RD
Armer, ML
Citation: Fn. Johnson et al., Gabapentin in the treatment of neuropathic pain, REV CONT PH, 12(3-4), 2001, pp. 125-211
Authors:
Dziedzicka-Wasylewska, M
Ferrari, F
Johnson, RD
Mierau, J
Rogoz, Z
Skuza, G
Sokoloff, P
Citation: M. Dziedzicka-wasylewska et al., Mechanisms of action of pramipexole: Effects on receptors, REV CONT PH, 12(1-2), 2001, pp. 1-31
Authors:
Bennett, JP
Carvey, PM
Hinds, TR
Johnson, RD
Le, WD
Phillips, W
Sethy, VH
Vincenzi, FF
Youdim, MBH
Citation: Jp. Bennett et al., Mechanisms of action of pramipexole: Putative neuroprotective effects, REV CONT PH, 12(1-2), 2001, pp. 33-57
Authors:
Lieberman, A
Minagar, A
Pinter, MM
Citation: A. Lieberman et al., The efficacy of pramipexole in the treatment of Parkinson's disease, REV CONT PH, 12(1-2), 2001, pp. 59-86
Authors:
Becker, PM
Corrigan, MH
Kasper, S
Lin, SC
Montplaisir, J
Szegedi, A
Willner, P
Citation: Pm. Becker et al., Clinical efficacy of pramipexole in the treatment of conditions other thanParkinson's disease, REV CONT PH, 12(1-2), 2001, pp. 87-104
Authors:
Armer, JA
Martin, WRW
Pogarell, O
Citation: Ja. Armer et al., Tolerability and safety profile of pramipexole in the treatment of Parkinson's disease, REV CONT PH, 12(1-2), 2001, pp. 105-124
Authors:
Leonard, BE
Citation: Be. Leonard, Noradrenaline and depression, REV CONT PH, 11(5), 2000, pp. 257-266
Authors:
Szabadi, E
Bradshaw, CM
Citation: E. Szabadi et Cm. Bradshaw, Mechanisms of action of reboxetine, REV CONT PH, 11(5), 2000, pp. 267-282
Authors:
Fleishaker, JC
Citation: Jc. Fleishaker, Pharmacokinetics and metabolism of reboxetine, REV CONT PH, 11(5), 2000, pp. 283-293
Authors:
Healy, D
Citation: D. Healy, The assessment of outcomes in depression: Measures of social functioning, REV CONT PH, 11(5), 2000, pp. 295-301
Authors:
De Maio, D
Johnson, FN
Citation: D. De Maio et Fn. Johnson, The clinical efficacy of reboxetine in the treatment of depression, REV CONT PH, 11(5), 2000, pp. 303-320
Authors:
Baldwin, DS
Buis, C
Carabal, E
Citation: Ds. Baldwin et al., Tolerability and safety of reboxetine, REV CONT PH, 11(5), 2000, pp. 321-330
Authors:
Black, CM
Byrne, G
Carlin, E
Gruber, F
Johnson, FN
Mardh, PA
McClarty, G
Marra, F
Nuovo, J
Ostergaard, L
Paavonen, J
Patton, DL
Quinn, TC
Raulston, JE
Robinson, A
Rosenn, MF
Scholes, D
Steingrimsson, O
Worm, AM
Wyrick, PB
Citation: Cm. Black et al., Chlamydia trachomatis genital infections and single-dose azithromycin therapy, REV CONT PH, 11(3-4), 2000, pp. 139-256
Authors:
Lipton, RB
Goadsby, PJ
Sawyer, JPC
Blakeborough, P
Stewart, WF
Citation: Rb. Lipton et al., Migraine: Diagnosis and assessment of disability, REV CONT PH, 11(2), 2000, pp. 63-73
Authors:
MacGregor, A
Citation: A. Macgregor, Gynaecological aspects of migraine, REV CONT PH, 11(2), 2000, pp. 75-90
Authors:
Goadsby, PJ
Peatfield, R
Citation: Pj. Goadsby et R. Peatfield, Zolmitriptan in the acute treatment of migraine: An overview, REV CONT PH, 11(2), 2000, pp. 91-97
Authors:
Nappi, G
Johnson, FN
Citation: G. Nappi et Fn. Johnson, The clinical efficacy of zolmitriptan, REV CONT PH, 11(2), 2000, pp. 99-118
Authors:
Edmeads, J
Johnson, FN
Citation: J. Edmeads et Fn. Johnson, The adverse event and tolerability profile of zolmitriptan, REV CONT PH, 11(2), 2000, pp. 119-132
Authors:
Meddis, D
Sawyer, JPC
Citation: D. Meddis et Jpc. Sawyer, Health economic outcomes in migraine: Impact of zolmitriptan, REV CONT PH, 11(2), 2000, pp. 133-138
Authors:
Bulmer, P
Abrams, P
Citation: P. Bulmer et P. Abrams, The overactive bladder, REV CONT PH, 11(1), 2000, pp. 1-11
Authors:
Nilvebrant, L
Citation: L. Nilvebrant, The mechanism of action of tolterodine, REV CONT PH, 11(1), 2000, pp. 13-27
Authors:
Malone-Lee, JG
Citation: Jg. Malone-lee, The efficacy, tolerability and safety profile of tolterodine in the treatment of overactive/unstable bladder, REV CONT PH, 11(1), 2000, pp. 29-42
Authors:
Luscombe, FA
Citation: Fa. Luscombe, Socioeconomic burden of urinary incontinence with focus on overactive bladder and tolterodine treatment, REV CONT PH, 11(1), 2000, pp. 43-62
Authors:
Johnson, FN
Citation: Fn. Johnson, The origins of lithium therapy, REV CONT PH, 10(4), 1999, pp. 193-265
Authors:
Baldassarre, JS
Pledger, GW
Citation: Js. Baldassarre et Gw. Pledger, Clinical trial design for new antiepileptic drugs: Determination of dose and titration schedules, REV CONT PH, 10(3), 1999, pp. 133-145